Welcome to our Q2 2023 Quarterly Report, carefully curated with topics that we believe will be of interest to our clients and partners. We also share M&A market commentaries and the latest Bryan, Garnier & Co deals in the healthcare, software, industrial tech, energy transition & sustainability, and testing and inspection sectors. The topics we cover:
- Unleashing the Protein Revolution: Cultivated proteins are revolutionizing the food industry with advancements in technology enabling the production of meat without animal slaughter, and recent regulatory approvals in the US and Europe are driving rapid market growth and attracting significant investments from food manufacturers.
- The Chip War is Heating Up! The chip war intensifies as Europe announces an EUR8 billion support package targeting the SME semiconductor ecosystem, aiming to boost its ambitions of producing 20% of global chips by 2030. Meanwhile, China’s export restrictions on key semiconductor materials and its recent ban on US-made memory chips signify a growing focus on strategic sectors, escalating the global chip war sparked by the COVID-19 pandemic.
- M&A deals activity: Gain valuable insights into the M&A market landscape in our sectors of expertise and the impact of the current macro environment as our partners provide their perspectives.
We hope these insights provide valuable information for investors interested in staying on top of the latest market trends.
We invite you to download the report for more valuable insights. Please contact us at communication@bryangarnier.com for any inquiries.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.